Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SP

Simon Paul Planken — 8 Patents

Pfizer: 8 patents #652 of 5,153Top 15%
San Marcos, CA: #194 of 897 inventorsTop 25%
California: #74,834 of 386,348 inventorsTop 20%
Overall (All Time): #600,572 of 4,157,543Top 15%
8 Patents All Time
Simon Paul Planken has been granted 8 US patents while listed as an inventor at Pfizer. The first was granted in 2011 and the most recent in April 2025. Simon Paul Planken ranks #600,572 of 4,157,543 US inventors in our database (top 14.4%). Patent records list Simon Paul Planken in San Marcos, CA, US.

Patents per Year

Patents granted per year, 2011 to 2025Bar chart with a peak of 2 patents in 2011.peak 22011: 2 patents20112015: 2 patents20152016: 1 patents20162020: 2 patents20202025: 1 patents2025

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12281127 Pyrido[4,3-d]pyrimidine compounds Benjamin Joseph Burke, Jacob Cole DeForest, Asako Nagata, Jillian Elyse SPANGLER, Scott Channing Sutton +2 more 2025-04-22
10662204 Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents Hengmiao Cheng, Michael Raymond Collins, Jillian Elyse SPANGLER, Alexei Brooun, Andreas Maderna +4 more 2020-05-26 $392,214,000
10590115 Tetrahydroquinazoline derivatives useful as anticancer agents Hengmiao Cheng, Michael Raymond Collins, Jillian Elyse SPANGLER, Alexei Brooun, Andreas Maderna +4 more 2020-03-17 $194,251,000
9290496 Purine derivatives Douglas C. Behenna, Hengmiao Cheng, Sujin Cho-Schultz, Theodore Otto Johnson, Jr., John Charles Kath +2 more 2016-03-22 $702,645,000
9056865 Pyridine-2-derivatives as smoothened receptor modulators Sajiv Krishnan Nair 2015-06-16 $141,497,000
9040547 Pyrrolopyrimidine and purine derivatives Hengmiao Cheng, Theodore Otto Johnson, Jr., John Charles Kath, Kevin Liu, Elizabeth Ann Lunney +3 more 2015-05-26 $303,449,000
7998978 Substituted 2-amino-fused heterocyclic compounds Liming Huang, Song Liu, Elizabeth Ann Lunney 2011-08-16 $563,148,000
7919488 Therapeutic compounds Scott Channing Sutton, Rongliang Chen 2011-04-05 $321,745,000